Dashboard
1
With a growth in Operating Profit of 50.93%, the company declared Very Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at SAR 739.69 MM
- INTEREST COVERAGE RATIO(Q) Highest at 2,511.47
- RAW MATERIAL COST(Y) Fallen by -9.2% (YoY)
2
With ROE of 22.50%, it has a very attractive valuation with a 3.99 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
SAR 10,704 Million (Small Cap)
18.00
NA
2.62%
-0.02
21.30%
3.41
Revenue and Profits:
Net Sales:
791 Million
(Quarterly Results - Mar 2026)
Net Profit:
173 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.76%
0%
-23.76%
6 Months
-23.24%
0%
-23.24%
1 Year
-3.5%
0%
-3.5%
2 Years
84.82%
0%
84.82%
3 Years
172.1%
0%
172.1%
4 Years
256.94%
0%
256.94%
5 Years
708.01%
0%
708.01%
Astra Industrial Group for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.44%
EBIT Growth (5y)
24.53%
EBIT to Interest (avg)
8.30
Debt to EBITDA (avg)
0.55
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.94
Tax Ratio
11.61%
Dividend Payout Ratio
41.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.01%
ROE (avg)
17.20%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
3.99
EV to EBIT
17.05
EV to EBITDA
15.24
EV to Capital Employed
3.96
EV to Sales
3.86
PEG Ratio
0.84
Dividend Yield
2.03%
ROCE (Latest)
23.21%
ROE (Latest)
22.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
790.90
791.80
-0.11%
Operating Profit (PBDIT) excl Other Income
213.00
142.40
49.58%
Interest
8.50
11.20
-24.11%
Exceptional Items
0.00
0.00
Consolidate Net Profit
173.10
138.20
25.25%
Operating Profit Margin (Excl OI)
242.90%
151.20%
9.17%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -0.11% vs 8.45% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 25.25% vs -17.39% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,070.70
3,062.30
0.27%
Operating Profit (PBDIT) excl Other Income
770.80
734.70
4.91%
Interest
50.80
107.30
-52.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
666.60
552.90
20.56%
Operating Profit Margin (Excl OI)
226.20%
215.00%
1.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.27% vs 8.61% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 20.56% vs 14.21% in Dec 2024
About Astra Industrial Group 
Astra Industrial Group
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






